Have a feature idea you'd love to see implemented?
Let us know!
SIBN SI-BONE Inc
Price (delayed)
$12.56
Market cap
$526.74M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.92
Enterprise value
$535.06M
SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a
Highlights
The EPS rose by 23% YoY and by 9% QoQ
The company's revenue rose by 19% YoY and by 4.2% QoQ
SI-BONE's quick ratio has decreased by 26% YoY and by 11% QoQ
The equity fell by 5% YoY
Key stats
What are the main financial stats of SIBN
Market
Valuations
Earnings
Shares outstanding
41.94M
Market cap
$526.74M
Enterprise value
$535.06M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.17
Price to sales (P/S)
3.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.41
Revenue
$157.04M
EBIT
-$33.87M
EBITDA
-$29.13M
Free cash flow
-$25.22M
Per share
Balance sheet
Liquidity
EPS
-$0.92
Free cash flow per share
-$0.6
Book value per share
$3.96
Revenue per share
$3.76
TBVPS
$5.44
Total assets
$227M
Total liabilities
$62.02M
Debt
$38.54M
Equity
$164.97M
Working capital
$179.02M
Debt to equity
0.23
Current ratio
8.25
Quick ratio
7.12
Net debt/EBITDA
-0.29
Margins
Efficiency
Dividend
EBITDA margin
-18.5%
Gross margin
77.7%
Net margin
-23.8%
Operating margin
-26.9%
Return on assets
-16.5%
Return on equity
-22.5%
Return on invested capital
-16%
Return on capital employed
-16.7%
Return on sales
-21.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SIBN stock price
How has the SI-BONE stock price performed over time
Intraday
2.2%
1 week
-2.79%
1 month
-3.24%
1 year
-29.95%
YTD
-40.16%
QTD
-10.16%
Financial performance
How have SI-BONE's revenue and profit performed over time
Revenue
$157.04M
Gross profit
$122.02M
Operating income
-$42.26M
Net income
-$37.4M
Gross margin
77.7%
Net margin
-23.8%
SI-BONE's net margin has increased by 28% YoY and by 12% from the previous quarter
The company's operating margin rose by 22% YoY and by 12% QoQ
The company's revenue rose by 19% YoY and by 4.2% QoQ
SI-BONE's net income has increased by 14% YoY and by 8% QoQ
Growth
What is SI-BONE's growth rate over time
Valuation
What is SI-BONE stock price valuation
P/E
N/A
P/B
3.17
P/S
3.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.41
The EPS rose by 23% YoY and by 9% QoQ
SIBN's P/B is 40% below its 5-year quarterly average of 5.3 and 21% below its last 4 quarters average of 4.0
The equity fell by 5% YoY
The P/S is 54% less than the 5-year quarterly average of 7.2 and 24% less than the last 4 quarters average of 4.4
The company's revenue rose by 19% YoY and by 4.2% QoQ
Efficiency
How efficient is SI-BONE business performance
The ROIC has grown by 35% YoY and by 11% from the previous quarter
The ROE has grown by 30% YoY and by 7% from the previous quarter
The ROS rose by 29% YoY and by 13% QoQ
SI-BONE's ROA has increased by 27% YoY and by 8% from the previous quarter
Dividends
What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SIBN.
Financial health
How did SI-BONE financials performed over time
SI-BONE's quick ratio has decreased by 26% YoY and by 11% QoQ
The current ratio has declined by 24% year-on-year and by 10% since the previous quarter
SI-BONE's debt is 77% less than its equity
The equity fell by 5% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.